I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
4.700
+0.060 (1.29%)
Oct 29, 2025, 11:00 AM EDT - Market open
I-Mab Market Cap
I-Mab has a market cap or net worth of $541.75 million as of October 29, 2025. Its market cap has increased by 423.82% in one year.
Market Cap
541.75M
Enterprise Value
372.70M
1-Year Change
423.82%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has increased from $138.05M to $541.75M, an increase of 292.44%. That is a compound annual growth rate of 26.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 534.83M | 672.66% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |